Apogee Therapeutics Inc (APGE)
NASDAQ
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Return on Assets (%) | -41.846 |
Return on Equity (%) | -44.213 |
Return on Invested Capital (%) | -49.012 |
Operating Margin (%) | N/A |
Net Profit Margin (%) | N/A |
Book Value Per Share | 7.497 |
Earnings Per Share | -1.657 |
Cash Per Share | 2.335 |
Working Capital Per Share | 7.457 |
Operating Profit Per Share | N/A |
EBIT Per Share | -1.657 |
EBITDA Per Share | -1.657 |
Free Cash Flow Per Share | -1.654 |
Year End December 30 2023 | 2023 |
---|---|
Current Ratio | 19.38 |
Quick Ratio | 19.236 |
Inventory Turnover (Days) | N/A |
Shares Outstanding | N/A |
Year End December 30 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|
USD ($) | |||
Shares Outstanding | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A |
Current Ratio | N/A | N/A | 38.077 |
Quick Ratio | N/A | N/A | 37.873 |
Inventory Turnover (Days) | N/A | N/A | N/A |
Market Cap | 2.92B |
Price to Earnings Ratio | -34.5 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 24.49 |
Price to Book Ratio | 7.63 |
Dividend Yield | - |
Shares Outstanding | 58.46M |
Average Volume (1 week) | 303.71k |
Average Volume (1 Month) | 434.2k |
52 Week Change | 140.16% |
52 Week High | 72.29 |
52 Week Low | 14.19 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.